Click Here to Request More Information

Early medical therapy for acute laryngeal injury (ALgI) after intubation:

Prospective, single-centre, double-blinded, randomized, control trial conducted at Vanderbilt Medical Center. Participants will be recruited from adult patients in ICUs. Participants will undergo an exam to identify of ALgI within 72 hours of extubation. Patients with ALgI will be randomized to placebo control or medical therapy (azithromycin 250 mg and budesonide 0.5 mg for 14 days). Laryngeal mobility and patient reported functional outcomes will be assessed 12 weeks after extubation.
https://clinicaltrials.gov/ct2/show/NCT02481817

Click Here to Request More Information

In the News

Here's what's happening with NoAAC:

11
APR

The 2016 AAO-HNSF Annual Meeting & OTO EXPO will be held Sunday, September 18 - Wednesday, September 21, 2016 in San Diego, CA.  For additional information on this year's Annual Meeting, please visit: http://www.entannualmeeting.org/16. Check...

18
MAR

During the annual Combined Otolaryngology Spring Meeting in Chicago, Illinois, NoAAC investigators are invited to attend a meeting and reception at The Gage restaurant on Thursday, May 19 from 11am-2pm. The Gage restaurant is located at 24 S Michigan Ave, about 5 blocks south of the COSM conference...

18
MAR

The Inaugural North American Airway Collaborative Symposium on Advanced Surgical Techniques in Adult Airway Reconstruction was held on February 22, 2016 in Baltimore, Maryland. Click here to view the Program Announcement

26
AUG

The NoAAC Network is holding a trial meeting concurrent with the American Academy of Otolaryngology-Head & Neck Surgery annual meeting in Dallas, Texas September 28th from 1-2pm in the Aloft Hotel....